Steroid acid-peptide based intracellular cargo delivery
AssigneeDefence Therapeutics Inc.
InventorSimon Beaudoin
Life of this patent
Estimating the term…
Loading patent…
AssigneeDefence Therapeutics Inc.
InventorSimon Beaudoin
Estimating the term…
Described herein are compositions and methods relating to cargoes for improved intracellular delivery. The compositions generally comprise a steroid acid-peptide conjugate covalently linked to and/or admixed with a cargo to be delivered intracellularly to target cells, resulting in increased intracellular and/or cytosolic/nuclear delivery of the cargo, increased presentation of the cargo by target cells, increased intracellular reactive oxygen species production in target cells, and/or the transformation of immunosuppressive cells into immunostimulatory and/or proinflammatory cells. Methods of improving cargo stability via covalent conjugation with steroid acid-peptide moieties are also described herein, as well as the use of steroid acid-peptide conjugates for enhanced genome editing and in the production of cell-based vaccines.
A composition comprising a steroid acid-peptide conjugate covalently linked to and/or admixed with a cargo for intracellular delivery.
A method for preparing a cargo for intracellular delivery having increased stability, the method comprising covalently linking the cargo to a sufficient number of steroid acid-peptide moieties to produce a covalently-modified cargo that exhibits greater stability (e.g., thermal stability) than the corresponding unmodified cargo.
A composition comprising an antigen covalently linked to and/or admixed with a steroid acid-peptide conjugate in an amount sufficient to improve presentation of the antigen upon administration of the composition to non-antigen presenting cells (e.g., mesenchymal stromal cells [MSCs]), as compared to administration of a corresponding composition lacking the steroid acid-peptide conjugate.
A cell culture comprising non-antigen presenting cells (e.g., mesenchymal stromal cells [MSCs]) pulsed with an antigen covalently linked to and/or admixed with a steroid acid-peptide conjugate.
Dependencies are inferred from the claim text.